Ann: Results of Meeting, page-2

I went to the meeting this arvo. No presentation just questions. 1st was NHS contract. Justin says the value is more than just financial, being recognized as a medical device for the 1st time is huge. Only hearable on list and is hugely cost beneficial to the nhs to prescribe buds rather than hearing aids due to self fitting and programming.

I forget the second question.

3rd was on capital raise. This is the completion of the last one where $10 mil was chased but $6 taken. It sounded like they expected the nhs deal a lot sooner and therefore they would get a better price. Not so, but i understand their reasoning.

Lives. Expected an announcement soon re: mass production. I am assuming the same time as capital raise completion. Nuheara are still developing as even if oem takes live forward, it is the basis of max and future platforms.

I left feeling confident this are going well.